Synergistic platelet antiaggregatory effects of the adenylate cyclase activator iloprost and the guanylate cyclase activating agent SIN-1 in vivo.
Spiecker, M
Synergistic platelet antiaggregatory effects of the adenylate cyclase activator iloprost and the guanylate cyclase activating agent SIN-1 in vivo. [electronic resource] - Thrombosis research Jun 1993 - 405-15 p. digital
Publication Type: Journal Article
0049-3848
10.1016/0049-3848(93)90082-y doi
Adenylyl Cyclase Inhibitors
Animals
Antihypertensive Agents--pharmacology
Blood Pressure--drug effects
Drug Synergism
Enzyme Activation--drug effects
Guanylate Cyclase--metabolism
Iloprost--pharmacology
Male
Molsidomine--analogs & derivatives
Nitric Oxide--metabolism
Platelet Aggregation--drug effects
Platelet Aggregation Inhibitors--pharmacology
Rats
Rats, Wistar
Signal Transduction--drug effects
Synergistic platelet antiaggregatory effects of the adenylate cyclase activator iloprost and the guanylate cyclase activating agent SIN-1 in vivo. [electronic resource] - Thrombosis research Jun 1993 - 405-15 p. digital
Publication Type: Journal Article
0049-3848
10.1016/0049-3848(93)90082-y doi
Adenylyl Cyclase Inhibitors
Animals
Antihypertensive Agents--pharmacology
Blood Pressure--drug effects
Drug Synergism
Enzyme Activation--drug effects
Guanylate Cyclase--metabolism
Iloprost--pharmacology
Male
Molsidomine--analogs & derivatives
Nitric Oxide--metabolism
Platelet Aggregation--drug effects
Platelet Aggregation Inhibitors--pharmacology
Rats
Rats, Wistar
Signal Transduction--drug effects